Exodus Point Capital Management, LP Bicycle Therapeutics PLC Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$18.95 - $28.67 $204,811 - $309,865	-10,808 Reduced 8.8%	111,973 $2.86 Million
Q1 2023 May 11, 2023	BUY	$20.02 - $31.37 $358,658 - $561,993	17,915 Added 17.08%	122,781 $2.61 Million
Q4 2022 Feb 13, 2023	BUY	$20.37 - $32.9 $533,368 - $861,453	26,184 Added 33.28%	104,866 $3.1 Million
Q3 2022 Nov 10, 2022	SELL	$17.49 - $28.44 $1.81 Million - $2.94 Million	-103,443 Reduced 56.8%	78,682 $1.83 Million
Q2 2022 Aug 19, 2022	BUY	$12.95 - $46.99 $2.36 Million - $8.56 Million	182,125 New	182,125 $3.06 Million

112

41.2M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $607M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.